Vanguard Group’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,952,120
Closed -$6.92M 4320
2025
Q1
$6.92M Sell
3,952,120
-14,971
-0.4% -$19.8K ﹤0.01% 3043
2024
Q4
$6.27M Sell
3,967,091
-121,669
-3% -$187K ﹤0.01% 3174
2024
Q3
$6.42M Buy
4,088,760
+37,897
+0.9% +$62.7K ﹤0.01% 3166
2024
Q2
$7.23M Buy
4,050,863
+3,310,648
+447% +$7.68M ﹤0.01% 3083
2024
Q1
$2.13M Buy
740,215
+453,784
+158% +$740K ﹤0.01% 3571
2023
Q4
$367K Buy
286,431
+1,381
+0.5% +$1.84K ﹤0.01% 4120
2023
Q3
$391K Buy
285,050
+2,390
+0.8% +$3.46K ﹤0.01% 4125
2023
Q2
$416K Hold
282,660
﹤0.01% 4169
2023
Q1
$240K Hold
282,660
﹤0.01% 4295
2022
Q4
$387K Buy
282,660
+160
+0.1% +$252 ﹤0.01% 4168
2022
Q3
$480K Sell
282,500
-90,232
-24% -$162K ﹤0.01% 4225
2022
Q2
$772K Buy
372,732
+4,899
+1% +$11.9K ﹤0.01% 4169
2022
Q1
$1.1M Buy
367,833
+64,812
+21% +$169K ﹤0.01% 4175
2021
Q4
$955K Sell
303,021
-7,484
-2% -$33.3K ﹤0.01% 4278
2021
Q3
$2.15M Buy
310,505
+981
+0.3% +$7.19K ﹤0.01% 4038
2021
Q2
$2.52M Sell
309,524
-12,552
-4% -$140K ﹤0.01% 3903
2021
Q1
$5.03M Buy
322,076
+283,410
+733% +$4.2M ﹤0.01% 3530
2020
Q4
$522K Buy
38,666
+28,121
+267% +$206K ﹤0.01% 3945
2020
Q3
$54K Buy
10,545
+7,295
+224% +$48K ﹤0.01% 4063
2020
Q2
$22K Hold
3,250
﹤0.01% 4057
2020
Q1
$15K Hold
3,250
﹤0.01% 4059
2019
Q4
$29K Hold
3,250
﹤0.01% 4071
2019
Q3
$23K Hold
3,250
﹤0.01% 4125
2019
Q2
$41K Sell
3,250
-1,107
-25% -$12.7K ﹤0.01% 4125
2019
Q1
$44K Sell
4,357
-18,161
-81% -$197K ﹤0.01% 4068
2018
Q4
$210K Buy
22,518
+729
+3% +$12.1K ﹤0.01% 3892
2018
Q3
$517K Sell
21,789
-338
-2% -$11.1K ﹤0.01% 3846
2018
Q2
$1.75M Sell
22,127
-1,077
-5% -$89.1K ﹤0.01% 3540
2018
Q1
$2M Buy
23,204
+2,698
+13% +$361K ﹤0.01% 3461
2017
Q4
$2.56M Sell
20,506
-3,419
-14% -$433K ﹤0.01% 3351
2017
Q3
$3.59M Buy
23,925
+11,672
+95% +$1.47M ﹤0.01% 3232
2017
Q2
$1.45M Sell
12,253
-455
-4% -$76K ﹤0.01% 3479
2017
Q1
$2.52M Buy
12,708
+7,028
+124% +$1.34M ﹤0.01% 3310
2016
Q4
$1.53M Sell
5,680
-5,463
-49% -$1.78M ﹤0.01% 3450
2016
Q3
$4.41M Buy
11,143
+489
+5% +$201K ﹤0.01% 3069
2016
Q2
$3.69M Buy
10,654
+855
+9% +$612K ﹤0.01% 3115
2016
Q1
$8.15M Buy
9,799
+597
+6% +$475K ﹤0.01% 2719
2015
Q4
$9.63M Buy
9,202
+676
+8% +$678K ﹤0.01% 2659
2015
Q3
$6.69M Buy
8,526
+1,007
+13% +$1.03M ﹤0.01% 2830
2015
Q2
$9.89M Buy
7,519
+463
+7% +$747K ﹤0.01% 2680
2015
Q1
$14.3M Buy
7,056
+693
+11% +$1.51M ﹤0.01% 2476
2014
Q4
$12.2M Buy
6,363
+2,423
+61% +$4.31M ﹤0.01% 2455
2014
Q3
$3.23M Buy
3,940
+178
+5% +$151K ﹤0.01% 3062
2014
Q2
$3.63M Buy
3,762
+267
+8% +$229K ﹤0.01% 2997
2014
Q1
$3.78M Buy
3,495
+1,469
+73% +$1.63M ﹤0.01% 2962
2013
Q4
$1.8M Buy
2,026
+130
+7% +$112K ﹤0.01% 3226
2013
Q3
$2.15M Buy
1,896
+1,292
+214% +$1.52M ﹤0.01% 3103
2013
Q2
$712K Buy
+604
New +$574K ﹤0.01% 3396

Other funds holding RGLS